Back to the Mental Health Monitor
Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health Monitor
80% of people diagnosed with anxiety, depression report losing years or decades of time
Video assets
Lost Time
Photo gallery
Courtney Nugent took a leave of absence from work when a mental health crisis sent her spiraling, but was able to return to teaching high school English after finding a medication that helped her.
Courtney Nugent, who was consumed by anxiety, unable to enjoy the things she loved, reads a book to relax. Nugent took the GeneSight test, which gave her clinician information about how she may break down or respond to certain mental health medications.
Sharon Philbin, APRN, specializes in mental health treatment at her practice in Pawtucket, RI. Philbin says it is common for patients to mourn time lost to anxiety and depression. She said mental health treatment may help them feel more present and get back to the things they love.
The GeneSight test helps providers make decisions on mental health medications and doses that may be more likely to help patients suffering from anxiety, depression, ADHD and other mental health conditions based on their unique genetic information.
Sharon Philbin, APRN, orders the GeneSight test, which provides a detailed report on how a patient may metabolize or respond to certain mental health medications based on their unique DNA.
The GeneSight Mental Health Monitor is a nationwide survey conducted online by ACUPOLL Precision Research, Inc. between February 16-21, 2024 among a representative sample (n=1000) of U.S. adults age 18+. The margin of error in survey results for the total base population at a 95% confidence interval is +/- 3%. A nationally representative sample of adults aged 18 years or older was recruited and balanced to match U.S. Census quotas across five primary metrics (i.e., age, gender, income, region, ethnicity).
In addition to the nationally representative sample, a statistically reliable sample was desired of respondents who were self-reported as being diagnosed by a medical professional with depression or anxiety. The study also used mental health screening instruments, the Patient Health Questionnaire-2 (PHQ-2) for depression, and the General Anxiety Disorder (GAD-2) for anxiety, to better understand this population.
ACUPOLL has more than 30 years of experience conducting statistically valid research through careful recruiting and quality control measures.